Human-GEM
Human-GEM copied to clipboard
Stereochemistry of Phytanic Acid Metabolism
Current behavior:
Human-GEM's representation of the stereochemistry of phytanic acid metabolites is inconsistent: some metabolites clearly specifically represent the (3S) enantiomers, while others seem to represent racemic mixtures of the (3S) and (3R) enantiomers:
| Metabolite/Reaction | unspecified/racemic version | S enantiomer |
|---|---|---|
| phytanic acid | MAM02746 |
doesn't exist |
| phytanoyl-CoA | MAM02747 |
MAM03362 |
| 2-hydroxyphytanoyl-CoA | MAM00655 |
MAM03363 |
| pristanal | doesn't exist | MAM00564 |
| pristanic acid | MAM02766 |
doesn't exist |
| pristanoyl-CoA | MAM03884 |
MAM00078 |
| phytanic acid [c] -> phytanoyl-CoA [c] | MAR03480 |
MAR03388 |
| phytanic acid [c] -> phytanic acid [x] | MAR03478 |
doesn't exist |
| phytanoyl-CoA [c] -> phytanoyl-CoA [x] | MAR06779 and MAR03481 |
doesn't exist |
| phytanic acid [x] -> phytanoyl-CoA [x] | MAR03482 |
MAR03389 |
| phytanoyl-CoA [x] -> 2-hydroxyphytanoyl-CoA [x] | MAR03484 |
MAR03384 |
| 2-hydroxyphytanoyl-CoA [x] -> pristanal [x] | MAR03486 |
MAR03385 |
| pristanal [x] -> pristanic acid [x] | MAR03386 |
doesn't exist |
| pristanic acid [x] -> pristanoyl-CoA [x] | MAR05183 |
MAR03387 |
Expected feature/value/output:
Apparently, most people's diets contain both (3S) and (3R)-phytanic acid, and while the enzymes responsible for the alpha-oxidation of phytanic acid (i.e. the enzymes responsible for the reactions mentioned in this issue) work with either enantiomer, the enzymes responsible for the beta-oxidation of pristanoyl-CoA only recognize (2S)-pristanoyl-CoA, so people who are born with defective AMACR (the enzyme responsible for converting (2R)-pristanoyl-CoA into (2S)-pristanoyl-CoA) can only fully metabolize (3S)-phytanic acid and accumulate (2R)-pristanic acid in their blood (source). In order to properly reflect this, I think the unspecified/racemic phytanic acid metabolites should be edited to instead represent the (3R)-enantiomers, and the reactions involving these two sets of metabolites should be fully separated from each other up until MAR03491, which already represents the isomerization of (2R)-pristanoyl-CoA and (2S)-pristanoyl-CoA by AMACR:
| Metabolite/Reaction | (S) version | (R) version |
|---|---|---|
| phytanic acid | MAM03884 |
MAM02746 |
| phytanoyl-CoA | MAM03362 |
MAM02747 |
| 2-hydroxyphytanoyl-CoA | MAM03363 |
MAM00655 |
| pristanal | MAM00564 |
need to make a new one |
| pristanic acid | MAM02766 |
MAM00077 |
| pristanoyl-CoA | MAM00078 |
MAM00075 |
| <-> phytanic acid [e] | MAR00659 |
MAR09037 |
| phytanic acid [e] -> phytanic acid [c] | MAR01617 |
MAR00440 |
| phytanic acid [c] -> phytanoyl-CoA [c] | MAR03388 |
MAR03480 |
| phytanoyl-CoA [c] -> phytanoyl-CoA [x] | MAR06779 |
MAR03481 |
| phytanic acid [x] -> phytanoyl-CoA [x] | MAR03389 |
MAR03482 |
| phytanoyl-CoA [x] -> 2-hydroxyphytanoyl-CoA [x] | MAR03384 |
MAR03484 |
| 2-hydroxyphytanoyl-CoA [x] -> pristanal [x] | MAR03385 |
MAR03486 |
| pristanal [x] -> pristanic acid [x] | MAR03386 |
MAR03488 |
| pristanic acid [x] -> pristanoyl-CoA [x] | MAR03387 |
MAR03493 |
I noticed that #646 removed the MAM03884 metabolites and all associated reactions for being duplicates of the MAM02746 metabolites, since both sets represent(ed) phytanic acid. I'm proposing to bring back the MAM03884 metabolites and reactions so that they can represent (3R)-phytanic acid, so that we can edit the MAM02746 metabolites and reactions to specifically represent (3S)-phytanic acid.
MAR03481 and MAR06779 both represent transport of phytanoyl-CoA from the cytosol into peroxisomes, but only MAR06779 correctly represents that this is an ATP-dependent process mediated by ABCD3 (source). Since they both use the racemic phytanoyl-CoA metabolite (MAM02747), and there is no equivalent reaction using (2S)-phytanoyl-CoA (MAM03362), I'm proposing to edit both reactions so that they both represent ATP-dependent import, but one uses (2S)-phytanoyl-CoA and the other uses (2R)-phytanoyl-CoA. Also it turns out that ABCD3 probably removes the CoA from its substrates just before it transports them across the peroxisomal membrane (source), so I'm also accounting for that in my proposed changes.
Proposed changes:
- [x] Rename
MAM02746e,MAM02746candMAM02746xto "(3R)-phytanic acid" - [x] Bring back
MAM03884e,MAM03884candMAM03884xand rename them to "(3S)-phytanic acid" - [x] Bring back
MAR00659andMAR01617(exchange and [e] <-> [c] transport reactions forMAM03884) - [x] Rename
MAM02747candMAM02747xto "(3R)-phytanoyl-CoA" - [x] Replace
MAM02746cwithMAM03884cinMAR03388 - [x] Edit
MAR03481to beMAM02747c + MAM01371c + 2 MAM02040c -> MAM02746x + MAM01597c + MAM02039c + MAM01285c + MAM02751c, GPR:ENSG00000117528, references:PMID:24333844;PMID:33500543 - [x] Edit
MAR06779to beMAM03362c + MAM01371c + 2 MAM02040c -> MAM03384x + MAM01597c + MAM02039c + MAM01285c + MAM02751c, GPR:ENSG00000117528, references:PMID:24333844;PMID:33500543 - [x] Replace
MAM02746xwithMAM03884xinMAR03389 - [x] Rename
MAM00655xto "(3R)-2-hydroxyphytanoyl-CoA" - [x] Create a new metabolite to represent peroxisomal (2R)-pristanal
- [x] Replace (2S)-pristanal (
MAM00564x) with the new (2R)-pristanal metabolite inMAR03486 - [x] Rename
MAM02766e,MAM02766c, andMAM02766xto "(2S)-pristanic acid" - [x] Bring back
MAR03488andMAM00077x, but replaceMAM00564xwith the new (2R)-pristanal metabolite inMAR03488 - [x] Replace
MAM02766xwithMAM00077xinMAR03493 - [x] Create
MAM00077candMAM00077eto represent cytosolic and extracellular (2R)-pristanic acid - [x] Replace
MAM02766cwithMAM00077cinMAR03390 - [x] Create new reactions like
MAR11966andMAR11967but withMAM00077candMAM000077einstead ofMAM02766candMAM02766e
These changes don't address the existence of Pristanoyl Coenzyme A (MAM03887) in addition to (2S)-pristanoyl-CoA (MAM00078) and (2R)-pristanoyl-CoA (MAM00075); that's taken care of in #776
3(S)-Phytanoyl-CoA (MAM03362c and MAM03362x) and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363x) seem to be entirely redundant with phytanoyl-CoA (MAM02747c and MAM02747x) and 2-hydroxyphytanoyl-CoA (MAM00655x)
@Devlin-Moyer if you have more evidence demonstrating that 3(S)-Phytanoyl-CoA (MAM03362c and MAM03362x) and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363x) are the same?
@Christoff1993 if you can help to double check this?
sorry I may not have written that super clearly; 3(S)-Phytanoyl-CoA (MAM03362) is the same as phytanoyl-CoA (MAM02747), and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363) is the same as 2-hydroxyphytanoyl-CoA (MAM00655)
I just came across this paper that mentions that people's diets usually consist of a racemic mixture of (3S)- and (3R)-phytanic acid, and while the enzymes responsible for the alpha-oxidation of phytanic acid to pristanal recognize either enantiomer, ACOX2 and ACOX3 (the enzymes responsible for the first step of beta-oxidation of pristanic acid) only act on 2S-pristanoyl-CoA, so people born with defective AMACR (the enzyme responsible for converting 2R-pristanoyl-CoA into 2S-pristanoyl-CoA) accumulate 2R-pristanic acid in their blood.
At the moment, it seems like MAM02746, MAM02747, and MAM00655x represent racemic phytanic acid, phytanoyl-CoA, and 2-hydroxyphytanoyl-CoA, and no metabolites that are currently present in Human-GEM specifically represent the 3R enantiomers. The stereochemistry gets even more confusing with the metabolites representing pristanal, pristanic acid, and pristanoyl-CoA; 2S-pristanal (MAM00564x) becomes (racemic?) pristanic acid (MAM02766x) in MAR03386, which can become 2S-pristanoyl-CoA (MAM00078x) in MAR03387, 2R-pristanoyl-CoA (MAM00075x) in MAR03493, or (racemic?) pristanoyl-CoA (MAM03887x) in MAR05183. The changes I proposed in the initial comment would basically remove any semblance of stereospecificity in this pathway; if we instead wanted to represent each enantiomer with a separate metabolite, we should:
- [ ] Rename
MAM02746e,MAM02746candMAM02746xto "(3R)-phytanic acid" - [ ] Rename
MAM02747candMAM02747xto "(3R)-phytanoyl-CoA" - [ ] Rename
MAM00655xto "(3R)-2-hydroxyphytanoyl-CoA" - [ ] Create a new metabolite to represent peroxisomal (2R)-pristanal
- [ ] Replace (2S)-pristanal (
MAM00564x) with the new (2R)-pristanal metabolite inMAR03486 - [ ] Bring back (2R,6S,10S)-pristanate (
MAM00077x),MAR03488, andMAR03489(they were removed in #519) - [ ] Replace (2S)-pristanal (
MAM00564x) with the new (2R)-pristanal metabolite inMAR03488 - [ ] Replace (2S)-pristanoyl-CoA (
MAM00078x) with (2R)-pristanoyl-CoA (MAM00075x) inMAR03489 - [ ] Create new metabolites for extracellular and cytosolic (3S)-phytanic acid as well as an exchange reaction and [e] <-> [c] transport reaction
- [ ] Replace
MAM02746cwith the new cytosolic (3S)-phytanic acid metabolite inMAR03388 - [ ] Create a new [c] <-> [x] transport reaction for the existing (3S)-phytanoyl-CoA metabolites (
MAM03362) - [ ] Keep
MAM03362c,MAM03362x,MAM03363x,MAR03384, andMAR03385exactly as they are (i.e. instead of removing them, as initially proposed in this issue) - [ ] Remove
MAR03389(currently converts phytanic acid (MAM02746x) to 3S-phytanoyl-CoA (MAM03362x);MAR03482converts phytanic acid (MAM02746x) to phytanoyl-CoA (MAM02747x), so if we rename both of those to (3R)-phytanic acid and (3R)-phytanoyl-CoA, we only want to keepMAR03482) - [ ] Remove
MAR05186andMAR05187(I already proposed this in #775 since they duplicateMAR03486+MAR03386in addition to being ambiguous about stereochemistry) - [ ] All changes proposed in #776
This would create two fully distinct series of metabolites and reactions for representing each pair of enantiomers that converge at MAR03491, which already interconverts (2R)-pristanoyl-CoA (MAM00075x) and (2S)-pristanoyl-CoA (MAM00078x):
| Reaction | ID using S-enantiomers | ID using R-enantiomers |
|---|---|---|
| Exchange of phytanic acid | new | MAR09037 |
| Transport of phytanic acid from [e] to [c] | new | MAR00440 |
| Transport of phytanic acid from [c] to [x] | not sure if necessary | MAR03478 |
| Phytanic acid to phytanoyl-CoA in [c] | MAR03388 |
MAR06779 |
| Transport of phytanoyl-CoA from [c] to [x] | new | MAR03481 |
| Phytanic acid to phytanoyl-CoA in [x] | not sure if necessary | MAR03482 |
| Phytanoyl-CoA to 2-hydroxyphytanoyl-CoA | MAR03384 |
MAR03484 |
| 2-hydroxyphytanoyl-CoA to pristanal | MAR03385 |
MAR03486 |
| Pristanal to pristanic acid | MAR03386 |
MAR03488 |
| Pristanic acid to pristanoyl-CoA | MAR03387 |
MAR03489 |
| Metabolite | S-enantiomer | R-enantiomer |
|---|---|---|
| Phytanic acid | new | MAM02746 |
| Phytanoyl-CoA | MAM03362 |
MAM02747 |
| 2-Hydroxyphytanoyl-CoA | MAM03363 |
MAM00655 |
| Pristanal | MAM00564 |
new |
| Pristanic acid | MAM02766 |
MAM00077 |
| Pristanoyl-CoA | MAM00078 |
MAM00075 |
I edited the proposed changes to try and accurately reflect the stereochemistry that's relevant to these reactions
I have checked the reasoning and citations, and everything seems comprehensive and sound: all the indicated ambiguities do indeed exist and the proposed changes will solve them. I have no disagreements/additional suggestions.